🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Treatment Gaining Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts directly for source information, while also receiving discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Some experts said the popularity for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate medicines, marketing, and consumer laws, risking fines, prosecution or prison.

Service Response and Content Elimination

According to TikTok, the platform has removed problematic content and banned related hashtags and query recommendations. The company said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.

Online Trading Operations

Research also discovered communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of members, populated with photos of slimming results, positive reviews and detailed guides for preparing or administering at residence.

After moments of joining one group, a vendor shared contact information, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, health issues or previous experience.

Item Details and Pricing

Within these communities, messages show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service stated it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they can’t verify. Even if the science behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose patients to potentially significant health risks”.